Profound Current Deferred Revenue vs Cash Analysis

PRN Stock

CAD 10.70 0.14 1.29%

Profound Medical financial indicator trend analysis is much more than just breaking down Profound Medical Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Profound Medical Corp is a good investment. Please check the relationship between Profound Medical Current Deferred Revenue and its Cash accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Current Deferred Revenue vs Cash

Current Deferred Revenue vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Profound Medical Corp Current Deferred Revenue account and Cash. At this time, the significance of the direction appears to have strong relationship.

The correlation between Profound Medical's Current Deferred Revenue and Cash is 0.63. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Cash in the same time period over historical financial statements of Profound Medical Corp, assuming nothing else is changed. The correlation between historical values of Profound Medical's Current Deferred Revenue and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Profound Medical Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Current Deferred Revenue i.e., Profound Medical's Current Deferred Revenue and Cash go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Cash

Cash refers to the most liquid asset of Profound Medical Corp, which is listed under current asset account on Profound Medical Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Profound Medical customers. The amounts must be unrestricted with restricted cash listed in a different Profound Medical account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most indicators from Profound Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Profound Medical's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 11th of December 2024, Enterprise Value is likely to grow to about 206.9 M, while Selling General Administrative is likely to drop about 6.9 M.

	2021	2022	2023	2024 (projected)
Interest Expense	303K	174K	770K	718.0K
Depreciation And Amortization	2.4M	2.1M	1.5M	1.4M

Interest Expense Depreciation And Amortization

Profound Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Total Assets		0.03	0.54	0.51	0.99	0.85	0.71	-0.97	-0.77	0.72	0.99	0.66	0.45	0.79	0.99	0.65	0.85	0.88	0.18	0.78	0.77	0.5	0.54	1.0	-0.14	0.36
Short Long Term Debt Total	0.03		0.63	0.6	-0.12	0.34	0.5	0.19	-0.38	0.41	-0.07	0.2	-0.08	0.3	-0.07	0.19	0.35	0.31	0.92	0.48	0.52	0.82	0.43	0.0	0.53	0.35
Other Current Liab	0.54	0.63		0.72	0.42	0.58	0.69	-0.39	-0.66	0.76	0.47	0.42	0.32	0.45	0.49	0.4	0.71	0.63	0.6	0.84	0.63	0.84	0.54	0.52	0.28	0.45
Total Current Liabilities	0.51	0.6	0.72		0.38	0.82	0.74	-0.32	-0.67	0.94	0.4	0.76	0.65	0.58	0.39	0.56	0.7	0.65	0.48	0.81	0.71	0.91	0.71	0.46	0.72	0.8
Total Stockholder Equity	0.99	-0.12	0.42	0.38		0.78	0.62	-0.99	-0.69	0.61	1.0	0.6	0.41	0.74	1.0	0.6	0.78	0.82	0.05	0.68	0.68	0.35	0.45	0.99	-0.26	0.26
Property Plant And Equipment Net	0.85	0.34	0.58	0.82	0.78		0.84	-0.73	-0.8	0.87	0.79	0.78	0.55	0.86	0.77	0.72	0.85	0.87	0.35	0.86	0.85	0.75	0.72	0.82	0.37	0.58
Current Deferred Revenue	0.71	0.5	0.69	0.74	0.62	0.84		-0.54	-0.92	0.78	0.63	0.51	0.43	0.89	0.63	0.69	0.91	0.92	0.55	0.91	0.94	0.8	0.83	0.7	0.33	0.3
Net Debt	-0.97	0.19	-0.39	-0.32	-0.99	-0.73	-0.54		0.61	-0.56	-0.99	-0.59	-0.37	-0.66	-0.99	-0.55	-0.71	-0.77	0.02	-0.61	-0.61	-0.28	-0.36	-0.97	0.32	-0.25
Retained Earnings	-0.77	-0.38	-0.66	-0.67	-0.69	-0.8	-0.92	0.61		-0.76	-0.7	-0.44	-0.5	-0.92	-0.7	-0.72	-0.98	-0.94	-0.5	-0.92	-0.91	-0.73	-0.88	-0.77	-0.18	-0.25
Accounts Payable	0.72	0.41	0.76	0.94	0.61	0.87	0.78	-0.56	-0.76		0.63	0.82	0.72	0.65	0.62	0.6	0.82	0.77	0.35	0.89	0.76	0.85	0.72	0.67	0.49	0.77
Cash	0.99	-0.07	0.47	0.4	1.0	0.79	0.63	-0.99	-0.7	0.63		0.6	0.38	0.73	1.0	0.6	0.79	0.83	0.09	0.7	0.69	0.39	0.46	0.99	-0.25	0.28
Non Current Assets Total	0.66	0.2	0.42	0.76	0.6	0.78	0.51	-0.59	-0.44	0.82	0.6		0.58	0.44	0.59	0.32	0.52	0.58	0.14	0.59	0.59	0.6	0.35	0.6	0.33	0.86
Non Currrent Assets Other	0.45	-0.08	0.32	0.65	0.41	0.55	0.43	-0.37	-0.5	0.72	0.38	0.58		0.35	0.37	0.58	0.51	0.49	-0.06	0.52	0.4	0.43	0.44	0.42	0.39	0.63
Other Assets	0.79	0.3	0.45	0.58	0.74	0.86	0.89	-0.66	-0.92	0.65	0.73	0.44	0.35		0.73	0.72	0.91	0.89	0.39	0.83	0.87	0.6	0.85	0.79	0.17	0.15
Cash And Short Term Investments	0.99	-0.07	0.49	0.39	1.0	0.77	0.63	-0.99	-0.7	0.62	1.0	0.59	0.37	0.73		0.58	0.79	0.82	0.09	0.71	0.68	0.38	0.45	0.99	-0.27	0.26
Net Receivables	0.65	0.19	0.4	0.56	0.6	0.72	0.69	-0.55	-0.72	0.6	0.6	0.32	0.58	0.72	0.58		0.71	0.75	0.35	0.61	0.69	0.54	0.67	0.66	0.21	0.31
Common Stock Total Equity	0.85	0.35	0.71	0.7	0.78	0.85	0.91	-0.71	-0.98	0.82	0.79	0.52	0.51	0.91	0.79	0.71		0.94	0.45	0.95	0.89	0.74	0.86	0.84	0.15	0.32
Common Stock Shares Outstanding	0.88	0.31	0.63	0.65	0.82	0.87	0.92	-0.77	-0.94	0.77	0.83	0.58	0.49	0.89	0.82	0.75	0.94		0.46	0.87	0.96	0.7	0.73	0.88	0.08	0.33
Non Current Liabilities Total	0.18	0.92	0.6	0.48	0.05	0.35	0.55	0.02	-0.5	0.35	0.09	0.14	-0.06	0.39	0.09	0.35	0.45	0.46		0.49	0.64	0.78	0.42	0.17	0.25	0.25
Other Current Assets	0.78	0.48	0.84	0.81	0.68	0.86	0.91	-0.61	-0.92	0.89	0.7	0.59	0.52	0.83	0.71	0.61	0.95	0.87	0.49		0.85	0.84	0.81	0.76	0.33	0.44
Other Stockholder Equity	0.77	0.52	0.63	0.71	0.68	0.85	0.94	-0.61	-0.91	0.76	0.69	0.59	0.4	0.87	0.68	0.69	0.89	0.96	0.64	0.85		0.8	0.75	0.75	0.21	0.38
Total Liab	0.5	0.82	0.84	0.91	0.35	0.75	0.8	-0.28	-0.73	0.85	0.39	0.6	0.43	0.6	0.38	0.54	0.74	0.7	0.78	0.84	0.8		0.69	0.46	0.56	0.66
Property Plant And Equipment Gross	0.54	0.43	0.54	0.71	0.45	0.72	0.83	-0.36	-0.88	0.72	0.46	0.35	0.44	0.85	0.45	0.67	0.86	0.73	0.42	0.81	0.75	0.69		0.53	0.44	0.25
Total Current Assets	1.0	0.0	0.52	0.46	0.99	0.82	0.7	-0.97	-0.77	0.67	0.99	0.6	0.42	0.79	0.99	0.66	0.84	0.88	0.17	0.76	0.75	0.46	0.53		-0.2	0.29
Short Term Debt	-0.14	0.53	0.28	0.72	-0.26	0.37	0.33	0.32	-0.18	0.49	-0.25	0.33	0.39	0.17	-0.27	0.21	0.15	0.08	0.25	0.33	0.21	0.56	0.44	-0.2		0.53
Intangible Assets	0.36	0.35	0.45	0.8	0.26	0.58	0.3	-0.25	-0.25	0.77	0.28	0.86	0.63	0.15	0.26	0.31	0.32	0.33	0.25	0.44	0.38	0.66	0.25	0.29	0.53

Click cells to compare fundamentals

Profound Medical Account Relationship Matchups

Profound Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	29.9M	104.6M	86.8M	64.4M	43.9M	46.2M
Short Long Term Debt Total	13.0M	1.7M	1.4M	8.2M	7.9M	6.9M
Other Current Liab	530.0K	757K	248K	919K	1.1M	703.0K
Total Current Liabilities	8.2M	4.8M	4.2M	4.2M	6.4M	5.1M
Total Stockholder Equity	14.3M	97.4M	80.6M	52.0M	31.2M	36.2M
Property Plant And Equipment Net	2.2M	2.3M	1.9M	1.7M	1.5M	1.4M
Current Deferred Revenue	501.2K	358K	477K	471K	721K	384.1K
Net Debt	(3.8M)	(82.2M)	(65.8M)	(38.3M)	(18.3M)	(19.2M)
Retained Earnings	(100.3M)	(130.0M)	(160.7M)	(189.4M)	(217.9M)	(207.0M)
Accounts Payable	3.0M	3.4M	3.2M	2.0M	3.3M	2.7M
Cash	14.7M	83.9M	67.2M	46.5M	26.2M	32.4M
Non Current Assets Total	7.2M	6.9M	9.7M	2.4M	2.0M	1.9M
Cash And Short Term Investments	14.7M	83.9M	67.2M	46.5M	26.2M	33.2M
Net Receivables	3.3M	7.4M	1.4M	6.3M	7.3M	3.7M
Common Stock Total Equity	98.4M	120.9M	130.3M	211.5M	243.3M	255.4M
Common Stock Shares Outstanding	11.1M	17.3M	20.5M	20.8M	21.2M	12.5M
Liabilities And Stockholders Equity	29.9M	104.6M	86.8M	64.4M	43.9M	46.2M
Non Current Liabilities Total	7.4M	2.4M	2.0M	8.2M	6.4M	5.2M
Inventory	3.6M	5.3M	7.4M	7.9M	7.0M	3.9M
Other Current Assets	1.0M	1.1M	1.1M	1.2M	1.4M	1.5M
Other Stockholder Equity	15.0M	11.3M	17.0M	18.7M	19.7M	11.3M
Total Liab	15.6M	7.3M	6.2M	12.4M	12.7M	10.1M
Property Plant And Equipment Gross	2.9M	2.3M	1.9M	1.7M	4.8M	5.0M
Total Current Assets	22.7M	97.7M	77.1M	62.0M	41.9M	41.4M
Accumulated Other Comprehensive Income	(89.7K)	4.6M	4.7M	16.8M	12.0M	12.6M
Short Term Debt	4.1M	312K	250K	762K	2.4M	1.7M
Intangible Assets	2.4M	1.9M	1.4M	680K	490K	465.5K
Common Stock	99.7M	211.5M	219.6M	205.8M	217.4M	135.6M
Other Liab	654K	1.1M	875K	764K	878.6K	1.1M
Net Tangible Assets	9.3M	92.8M	76.5M	51.3M	59.0M	38.9M
Long Term Debt	10.6M	6.7M	0.0	6.7M	5M	5.3M
Long Term Debt Total	8.8M	1.4M	1.1M	7.5M	8.6M	5.4M
Capital Surpluse	19.6M	11.3M	17.0M	18.7M	21.5M	13.0M
Short Long Term Debt	4.7M	1.3M	5.1M	523K	2.1M	2.7M
Property Plant Equipment	2.2M	2.3M	1.9M	1.7M	2.0M	1.7M
Net Invested Capital	23.4M	97.4M	80.6M	59.2M	38.3M	53.8M

Pair Trading with Profound Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.

The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:

How To Invest In Profound

Details

Is Profound Stock a good investment?

Details

What is Profound Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Profound Current Deferred Revenue vs Cash Analysis

Current Deferred Revenue vs Cash

Current Deferred Revenue vs Cash Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Cash

Profound Medical fundamental ratios Correlations

Profound Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Profound Medical fundamental ratios Accounts

Pair Trading with Profound Medical

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Common Stock Total Equity	- 0.98	Retained Earnings
Total Current Assets	- 0.97	Net Debt
Net Debt	- 0.97	Total Assets